Discover how to access our new National Mobile Phlebotomy Service for blood-based tests, which helps to guarantee efficient cancer diagnosis during COVID-19 To find out more, please contact Client Services at 1-866-776-5907 or visit our website: https://bit.ly/3f62 vNn
At NeoGenomics, we understand the obstacles of COVID-19 for oncology clients and the impact it has had on accessing prompt cancer screening– that’s why we’ve released our National Mobile Phlebotomy Service. Tests offered consist of InVisionFirst ®- Lung, advanced non-small cell lung cancer liquid biopsy test, and the NeoLAB ® liquid biopsy suite of tests including solid growth and hematologic cancers. With this in-home service we can attend to client fears of direct exposure to COVID-19 and help to ensure the effective connection of care that is so vital in the treatment and monitoring of cancer clients.
http://phlebotomycareertraining.org/how-to-gain-access-to-neogenomics-national-mobile-phlebotomy-program/
No comments:
Post a Comment